GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 28, 2024
Displaying entries 30651 - 30700 of 39437 in total
PDB ID UniProt ID ▲ Title Descriptor
6V6W Q2N0S6 Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22
6X9T Q2N0S6 HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
6X9U Q2N0S6 HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
6X9V Q2N0S6 HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
6XRT Q2N0S6 Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain
7LOK Q2N0S6 Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein BG505 SOSIP.664 gp120, 17b Fab Light Chain, 17b Fab Heavy Chain, M48U1
6CUE Q2N0S6 Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6N1W Q2N0S6 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6OSY Q2N0S6 Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
6V0R Q2N0S6 BG505 SOSIP.664 Trimer BG505 SOSIPv5.2 gp120, BG505 SOSIPv5.2 gp41
6X9R Q2N0S6 HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
6X9S Q2N0S6 HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain
5V7J Q2N0S6 Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22.
5V8L Q2N0S6 BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 gp120, gp41, 3BNC117 antibody, heavy chain, PGT145 antibody, heavy chain, 3BNC117 antibody, light chain, PGT145 antibody, light chain
5VIY Q2N0S6 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5WDU Q2N0S6 HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv
6B0N Q2N0S6 Crystal structure of the cleavage-independent prefusion HIV Env glycoprotein trimer of the clade A BG505 isolate (NFL construct) in complex with Fabs PGT122 and PGV19 at 3.39 A
6DFG Q2N0S6 BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6MTN Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MU8 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6OT1 Q2N0S6 Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, Envelope glycoprotein gp41, VRC03 Heavy Chain, VRC03 Light Chain, PGT122 Heavy Chain, PGT122 Light Chain, 0PV-c.01 Heavy Chain, 0PV-c.01 Light Chain
6UDJ Q2N0S6 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UTK Q2N0S6 Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom
6VI0 Q2N0S6 Cryo-EM structure of VRC01.23 in complex with HIV-1 Env BG505 DS.SOSIP
6VKN Q2N0S6 BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
7LO6 Q2N0S6 Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab Envelope glycoprotein gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, 17b Fab Light Chain, 17b Fab Heavy Chain
6MU7 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6V8X Q2N0S6 VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
7LG6 Q2N0S6 BG505 SOSIP.v5.2 in complex with VRC40.01 and RM19R Fabs
8EUU Q2N0S6 Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01 FAB
8EUV Q2N0S6 Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-COMBO1 FAB
8EUW Q2N0S6 Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-MM28 FAB
8TNG Q2N0S6 Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody R27 targeting the CD4-binding site
8TNH Q2N0S6 Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody G36 targeting the CD4-binding site
8TNI Q2N0S6 Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing bi-specific antibody CAP256L-R27 targeting the CD4-binding site and the V2-apex
4NCO Q2N0S6 Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizing Fab PGT122
4ZMJ Q2N0S6 Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer
5ACO Q2N0S6 Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer HIV-1 ENVELOPE GLYCOPROTEIN, PGT128 FAB
5C7K Q2N0S6 Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT128 and 8ANC195
5CEZ Q2N0S6 Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with an early putative precursor of the PGT121 family at 3.0 Angstrom
5CJX Q2N0S6 Crystal structure of 8ANC195 Fab in complex with BG505 SOSIP.664 HIV-1 Env trimer
5D9Q Q2N0S6 Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizing Fab PGT122 and scFv NIH45-46
5FYL Q2N0S6 Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122 and 35O22
5I8H Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting Antibody PGT122 Fab and Fusion Peptide-targeting Antibody VRC34.01 Fab BG505 SOSIP.664 gp120, BG505 SOSIP.664 gp41, PGT122 Fab light chain, VRC34.01 Fab heavy chain, VRC34.01 Fab light chain, PGT122 Fab heavy chain
6DE7 Q2N0S6 Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Interdomain Stabilization 113C-429GCG in Complex with Broadly Neutralizing Antibodies PGT122 and 35O22
6MAR Q2N0S6 HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151, Light chain, Envelope glycoprotein gp160
6V8Z Q2N0S6 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6VN0 Q2N0S6 BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6W03 Q2N0S6 Crystal Structure of HIV-1 BG505 DS-SOSIP.3mut Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.3 Angstrom
7MXE Q2N0S6 Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024